Europe PMC
open access
Macrolide-resistant <i>Mycobacterium avium</i> complex pulmonary disease: A narrative review
Mycobacterium avium complex pulmonary disease (MAC-PD) is on the rise across the world, where only about two-thirds are cured by current treatment strategies. Treatment of MAC-PD includes macrolides as the key drug in a three-drug regimen, making the emergence of macrolide resistance particul
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Single-cell and spatial profiling highlights TB-induced myofibroblasts as drivers of lung pathology#326650
- Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer#811681
- Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis#1120406
- SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC#245495
- Persistent Lung Inflammation and Fibrosis After Mouse-Adapted Omicron BA.1 Infection#359218
Record · ID 922272
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive